LOCALIZED GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for LOCALIZED GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALIZED GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALIZED GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost stomach cancer treatment before surgery
Disease control OngoingThis study tests whether combining two immunotherapy drugs (nivolumab and ipilimumab) with chemotherapy and radiation before surgery can safely treat stomach cancer. About 32 adults with resectable gastric or gastroesophageal junction cancer will receive this combination. The goa…
Matched conditions: LOCALIZED GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Immunotherapy plus chemoradiation shows promise for Hard-to-Treat stomach cancer
Disease control OngoingThis early-phase trial tested a combination of the immunotherapy drug pembrolizumab with chemotherapy and radiation in 16 people whose gastroesophageal cancer could not be removed by surgery. The goal was to see if the treatment could shrink or eliminate the cancer. The study is …
Matched conditions: LOCALIZED GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 22, 2026 16:00 UTC